SCHEMBL1340422

SCHEMBL1340422

NC(=O)[C@@H]1[C@H]2C[C@H]2CN1C(=O)c1sccc1-c1ccc(F)cc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 9/20 0.40
BCAT2 O15382 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
PTGS2 P35354 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
PIK3CA P42336 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SLC18A3 Q16572 2/20 0.32
PAX8 Q06710 1/20 0.31
SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3412456 0.89 HCRTR1 (0.39) BCAT2HCRTR1HCRTR2PTGS2L3MBTL1
SCHEMBL1340425 0.84 PTGS1 (0.38) PTGS1BCAT2HCRTR1HCRTR2PTGS2
SCHEMBL1339841 0.83 PTGS1 (0.41) PTGS1PTGS2L3MBTL1PIK3CANPC1
SCHEMBL3413481 0.81 HCRTR1 (0.41) BCAT2HCRTR1HCRTR2L3MBTL1ALDH1A1
SCHEMBL3415826 0.80 HCRTR1 (0.44) BCAT2HCRTR1HCRTR2ALDH1A1TSHR
SCHEMBL2925286 0.80 HCRTR1 (0.44) BCAT2HCRTR1HCRTR2ALDH1A1TSHR
SCHEMBL3417316 0.79 CA12 (0.40) PIK3CA
SCHEMBL3415462 0.77 HCRTR1 (0.40) HCRTR1HCRTR2PTGS2PIK3CA
SCHEMBL2931970 0.76 GRM2 (0.37) HCRTR1HCRTR2ALDH1A1TSHRSMN1; SMN2
SCHEMBL3412461 0.75 HCRTR1 (0.41) BCAT2HCRTR1HCRTR2PTGS2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063099-B2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2011-11-22 US disclosed
EP-2185512-B1 TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2010-12-29 EP disclosed